We are live on ! Find out more
TYRA icon

Tyra Biosciences
TYRA

26 hedge funds and large institutions have $457M invested in Tyra Biosciences in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

61.31% more ownership

Funds ownership: 0% → 61.31% (+61%)

Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$138M
2
BC
Boxer Capital
California
+$121M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$36.5M
4
BI
BVF Inc
California
+$32.4M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$26.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$127M +$138M +7,236,454 New
BC
2
Boxer Capital
California
$111M +$121M +6,323,359 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$33.6M +$36.5M +1,908,659 New
BI
4
BVF Inc
California
$29.8M +$32.4M +1,694,933 New
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$22.8M +$26.3M +1,374,648 New
FM
6
Frazier Management
Washington
$22M +$23.9M +1,250,000 New
CAM
7
Cormorant Asset Management
Massachusetts
$18.2M +$20.4M +1,069,932 New
LGM
8
Logos Global Management
California
$17.6M +$19.2M +1,003,394 New
PA
9
Perceptive Advisors
New York
$17.4M +$18.9M +987,500 New
Wellington Management Group
10
Wellington Management Group
Massachusetts
$12.2M +$13.3M +695,371 New
DM
11
Deerfield Management
New York
$11M +$11.9M +625,000 New
FFM
12
Fairmount Funds Management
Pennsylvania
$8.78M +$9.54M +499,040 New
Jennison Associates
13
Jennison Associates
New York
$8.24M +$8.96M +468,750 New
WP
14
Woodline Partners
California
$6.44M +$7M +366,035 New
Goldman Sachs
15
Goldman Sachs
New York
$3.65M +$3.96M +207,283 New
Ensign Peak Advisors
16
Ensign Peak Advisors
Utah
$2.2M +$2.39M +125,000 New
Millennium Management
17
Millennium Management
New York
$1.65M +$1.79M +93,501 New
LP
18
LMR Partners
United Kingdom
$950K +$1.03M +54,000 New
HF
19
HRT Financial
New York
$559K +$608K +31,805 New
PCM
20
Pinz Capital Management
New York
$487K +$529K +27,700 New
SRC
21
Samson Rock Capital
United Kingdom
$269K +$292K +15,267 New
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$202K +$219K +11,456 New
MS
23
Maven Securities
Jersey
$178K +$194K +10,140 New
Bank of America
24
Bank of America
North Carolina
$15K +$16.9K +885 New
Citigroup
25
Citigroup
New York
$8K +$8.41K +440 New
1
2

TYRA Hedge Fund Activity: Q3 2021 in Review

26 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q3 2021, worth a combined $457M.

Buyers outnumbered sellers: 26 funds opened new TYRA positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $138M.

  • 26 institutional investors held Tyra Biosciences (TYRA) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $457M of Tyra Biosciences stock for Q3 2021.
  • 26 funds opened new Tyra Biosciences positions in Q3 2021 and 0 closed out, a net change of +26 holders.
  • The largest Tyra Biosciences buyer in Q3 2021 was RA Capital Management, an estimated $138M added.

Based on aggregated 13F filings for Q3 2021.